Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Remco Nijmeijer

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Cardiovascular & Hematological Disorders Drug Targets|June 22, 2006
Inhibition of sPLA2-IIA, C-reactive protein or complement: new therapy for patients with acute myocardial infarction?Paul A J Krijnen, Christof Meischl, Remco Nijmeijer, et al.
The American Journal of Pathology|June 24, 2003
C-reactive protein activates complement in infarcted human myocardiumRemco Nijmeijer, Wim K Lagrand, Yvonne T P Lubbers, et al.
Cardiovascular Research|December 18, 2001
Secretory type II phospholipase A(2) binds to ischemic myocardium during myocardial infarction in humansRemco Nijmeijer, Wim K Lagrand, Alexi Baidoshvili, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Cardiovascular & Hematological Disorders Drug Targets|June 22, 2006
Inhibition of sPLA2-IIA, C-reactive protein or complement: new therapy for patients with acute myocardial infarction?Paul A J Krijnen, Christof Meischl, Remco Nijmeijer, et al.
The American Journal of Pathology|June 24, 2003
C-reactive protein activates complement in infarcted human myocardiumRemco Nijmeijer, Wim K Lagrand, Yvonne T P Lubbers, et al.
Cardiovascular Research|December 18, 2001
Secretory type II phospholipase A(2) binds to ischemic myocardium during myocardial infarction in humansRemco Nijmeijer, Wim K Lagrand, Alexi Baidoshvili, et al.
Pageof 1